Rifamycin SV-MMX(®) for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria

BACKGROUND: The novel oral antibiotic formulation Rifamycin SV-MMX(®), with a targeted delivery to the distal small bowel and colon, was superior to placebo in treating travellers’ diarrhea (TD) in a previous study. Thus, a study was designed to compare this poorly absorbed antibiotic with the syste...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Travel Med
Hlavní autoři: Steffen, Robert, Jiang, Zhi-Dong, Gracias Garcia, Mónica L, Araujo, Prithi, Stiess, Michael, Nacak, Tanju, Greinwald, Roland, DuPont, Herbert L
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6331114/
https://ncbi.nlm.nih.gov/pubmed/30462260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jtm/tay116
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky